- Home
- SUZ vs FMS Comparison
SUZ vs FMS Comparison
Compare SUZ & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUZ
- FMS
- Stock Information
- Founded
- SUZ 1924
- FMS 1996
- Country
- SUZ Brazil
- FMS Germany
- Employees
- SUZ N/A
- FMS N/A
- Industry
- SUZ Paper
- FMS Misc Health and Biotechnology Services
- Sector
- SUZ Basic Materials
- FMS Health Care
- Exchange
- SUZ Nasdaq
- FMS Nasdaq
- Market Cap
- SUZ 12.8B
- FMS 14.1B
- IPO Year
- SUZ N/A
- FMS 1996
- Fundamental
- Price
- SUZ $9.94
- FMS $23.53
- Analyst Decision
- SUZ
- FMS Hold
- Analyst Count
- SUZ 0
- FMS 1
- Target Price
- SUZ N/A
- FMS $23.00
- AVG Volume (30 Days)
- SUZ 2.0M
- FMS 214.6K
- Earning Date
- SUZ 10-24-2024
- FMS 11-05-2024
- Dividend Yield
- SUZ 2.27%
- FMS 2.69%
- EPS Growth
- SUZ N/A
- FMS 46.47
- EPS
- SUZ 0.60
- FMS 2.50
- Revenue
- SUZ $8,006,653,403.00
- FMS $21,457,738,113.00
- Revenue This Year
- SUZ $14.70
- FMS $0.24
- Revenue Next Year
- SUZ $10.62
- FMS $3.41
- P/E Ratio
- SUZ $17.01
- FMS $19.12
- Revenue Growth
- SUZ N/A
- FMS N/A
- 52 Week Low
- SUZ $8.78
- FMS $17.93
- 52 Week High
- SUZ $12.98
- FMS $24.31
- Technical
- Relative Strength Index (RSI)
- SUZ 40.38
- FMS 62.61
- Support Level
- SUZ $10.28
- FMS $23.54
- Resistance Level
- SUZ $10.65
- FMS $24.07
- Average True Range (ATR)
- SUZ 0.20
- FMS 0.27
- MACD
- SUZ -0.06
- FMS -0.05
- Stochastic Oscillator
- SUZ 2.11
- FMS 72.58
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.